Sunitinib based drugs: price, availability and description

Sunitinib is a potent tyrosine kinase inhibitor that suppresses cancer cell growth and blocks angiogenesis (blood vessel formation), starving the tumor. It is indicated for the treatment of gastrointestinal stromal tumors (GIST) after failure of imatinib, advanced renal cell carcinoma (RCC), and unresectable pancreatic neuroendocrine tumors (pNET).